V
Power Law company profile
Veracyte
Biotech & Life Sciences · San Francisco, United States · Founded 2008 · IPO 2013 Unicorn
Valuation
$2.16B
Market cap · Apr/2026
Revenue
$516M
Latest reported FY
Global footprint
Where Veracyte has talent and traffic
AI talent share
2.0%
of workforce is AI talent
(14 of 701 staff)
(14 of 701 staff)
Core AI10.14%
Other AI131.85%
Non-AI workforce68798%
Web traffic by country
81K
monthly visits
across markets
across markets
🇺🇸 United States83.7%
🇮🇳 India6.4%
🇨🇦 Canada1.7%
🇬🇧 United Kingdom1.7%
🏳️ Russian Federation1.7%
Patent intelligence
$35M patent portfolio · 38 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$35M
1.6% of market cap · 1086.7× the top peer Sema4 ($32k)
38 active patent families
Where Veracyte innovates
PathologyOncologyBiologyCancer researchInternal medicine
Below peer median on Legal
Quality vs same-sector peers
Veracyte on the five Patsnap quality dimensions
Veracyte in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Veracyte concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Veracyte and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Veracyte on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.